Thrombomodulin expression in colorectal carcinoma is protective and correlates with survival

British Journal of Cancer

Volumn 94, Issue 9, 2006, Pages 1320-1325

  Hanly, A M ^a   Redmond, M ^a   Winter, D C ^a   Brophy, S ^a   Deasy, J M ^a   Bouchier Hayes, D J ^a   Kay, E W ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Colorectal; Thrombomodulin

Indexed keywords

CELL RECEPTOR; FORMALDEHYDE; PARAFFIN; THROMBIN; THROMBOMODULIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CELL PROTECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JASS SCORE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL RATE; TISSUE DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL ANALYSIS; THROMBOMODULIN;

EID: 33646496599     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603098     Document Type: Article

References (37)

1. Calnek DS, Grinnell BW (1998) Thrombomodulin-dependent anticoagulant activity is regulated by vascular endothelial growth factor. Exp Cell Res 238: 294-298
2. Conway EM, Van de Wouwer M, Pollefeyt S, Jurk K, Van Aken H, De Vriese A, Weitz JI, Weiler H, Hellings PW, Schaeffer P, Herbert JM, Collen D, Theilmeier G (2002) The lectin-like domain of thrombomodulin confers protection from neutrophil-mediated tissue damage by suppressing adhesion molecule expression via nuclear factor kappaB and mitogen-activated protein kinase pathways. J Exp Med 196: 565-577
3. de Munk GA, Groeneveld E, Rijken DC (1991) Acceleration of the thrombin inactivation of single chain urokinase-type plasminogen activator (pro-urokinase) by thrombomodulin. J Clin Invest 88: 1680-1684
4. Dittman WA, Kumada T, Majerus PW (1989) Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin. Proc Natl Acad Sci USA 86: 7179-7182
5. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264: 4743-4746
6. Esmon CT, Owen WG (1981) Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 78: 2249-2252
7. Esmon CT, Owen WG (2004) The discovery of thrombomodulin. J Thromb Haemost 2: 209-213
8. Grey ST, Csizmadia V, Hancock WW (1998) Differential effect of tumor necrosis factor-alpha on thrombomodulin gene expression by human monocytoid (THP-1) cell vs endothelial cells. Int J Hematol 67: 53-62
9. Hamatake M, Ishida T, Mitsudomi T, Akazawa K, Sugimachi K (1996) Prognostic value and clinicopathological correlation of thrombomodulin in squamous cell carcinoma of the human lung. Clin Cancer Res 2: 763-766
10. Hanly AM, Hayanga A, Winter DC, Bouchier-Hayes DJ (2005) Thrombomodulin: tumour biology and prognostic implications. Eur J Surg Oncol 31: 217-220
11. Hosaka Y, Higuchi T, Tsumagari M, Ishii H (2000) Inhibition of invasion and experimental metastasis of murine melanoma cells by human soluble thrombomodulin. Cancer Lett 161: 231-240
12. Huang HC, Shi GY, Jiang SJ, Shi CS, Wu CM, Yang HY, Wu HL (2003) Thrombomodulin-mediated cell adhesion: involvement of its lectin-like domain. J Biol Chem 278: 46750-46759
13. Iino S, Abeyama K, Kawahara K, Yamakuchi M, Hashiguchi T, Matsukita S, Yonezawa S, Taniguchi S, Nakata M, Takao S, Aikou T, Maruyama I (2004) The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value. Clin Cancer Res 10: 6179-6188
14. Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S (2002) Effects of human soluble thrombomodulin on experimental glomerulonephritis. Kidney Int 61: 490-501
15. Imada S, Yamaguchi H, Nagumo M, Katayanagi S, Iwasaki H, Imada M (1990) Identification of fetomodulin, a surface marker protein of fetal development, as thrombomodulin by gene cloning and functional assays. Dev Biol 140: 113-122
16. Iqbal S (2000) Role of thrombomodulin in cancer biology. Breast 9: 264-266
17. Ishii H, Tezuka T, Ishikawa H, Takada K, Oida K, Horie S (2003) Oxidized phospholipids in oxidized low-density lipoprotein down-regulate thrombomodulin transcription in vascular endothelial cells through a decrease in the binding of RARbeta-RXRalpha heterodimers and Sp1 and Sp3 to their binding sequences in the TM promoter. Blood 101: 4765-4774
18. Jackson DE, Mitchell CA, Bird P, Salem HH, Hayman JA (1995) Immunohistochemical localization of thrombomodulin in normal human skin and skin tumours. J Pathol 175: 421-432
19. Kim SJ, Shiba E, Ishii H, Inoue T, Taguchi T, Tanji Y, Kimoto Y, Izukura M, Takai S (1997) Thrombomodulin is a new biological and prognostic marker for breast cancer: an immunohistochemical study. Anticancer Res 17: 2319-2323
20. Lindahl AK, Boffa MC, Abildgaard U (1993) Increased plasma thrombomodulin in cancer patients. Thromb Haemost 69: 112-114
21. Maruyama I, Bell CE, Majerus PW (1985) Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol 101: 363-371
22. Matsushita Y, Yoshiie K, Imamura Y, Ogawa H, Imamura H, Takao S, Yonezawa S, Aikou T, Maruyama I, Sato E (1998) A subcloned human esophageal squamous cell carcinoma cell line with low thrombomodulin expression showed increased invasiveness compared with a high thrombomodulin-expressing clone - thrombomodulin as a possible candidate for an adhesion molecule of squamous cell carcinoma. Cancer Lett 127: 195-201
23. Mizutani H, Ohyanagi S, Hayashi T, Groves RW, Suzuki K, Shimizu M (1996) Functional thrombomodulin expression on epithelial skin tumours as a differentiation marker for suprabasal keratinocytes. Br J Dermatol 135: 187-193
24. Ogawa H, Yonezawa S, Maruyama I, Matsushita Y, Tezuka Y, Toyoyama H, Yanagi M, Matsumoto H, Nishijima H, Shimotakahara T, Aikou T, Sato E (2000) Expression of thrombomodulin in squamous cell carcinoma of the lung: its relationship to lymph node metastasis and prognosis of the patients. Cancer Lett 149: 95-103
25. Ohji T, Urano H, Shirahata A, Yamagishi M, Higashi K, Gotoh S, Karasaki Y (1995) Transforming growth factor beta 1 and beta 2 induce down-modulation of thrombomodulin in human umbilical vein endothelial cells. Thromb Haemost 73: 812-818
26. Ordonez NG (1997) Value of thrombomodulin immunostaining in the diagnosis of transitional cell carcinoma: a comparative study with carcinoembryonic antigen. Histopathology 31: 517-524
27. Shi J, Wang J, Zheng H, Ling W, Joseph J, Li D, Mehta JL, Ponnappan U, Lin P, Fink LM, Hauer-Jensen M (2003) Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. Blood Coagul Fibrinolysis 14: 575-585
28. Tabata M, Sugihara K, Yonezawa S, Yamashita S, Maruyama I (1997) An immunohistochemical study of thrombomodulin in oral squamous cell carcinoma and its association with invasive and metastatic potential. J Oral Pathol Med 26: 258-264
29. Tabata M, Yonezawa S, Sugihara K, Yamashita S, Maruyama I (1995) The use of thrombomodulin to study epithelial cell differentiation in neoplastic and non-neoplastic oral lesions. J Oral Pathol Med 24: 443-449
30. Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T (1995) The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett 92: 1-7
31. Tezuka Y, Yonezawa S, Maruyama I, Matsushita Y, Shimizu T, Obama H, Sagara M, Shirao K, Kusano C, Natsugoe S (1995) Expression of thrombomodulin in esophageal squamous cell carcinoma and its relationship to lymph node metastasis. Cancer Res 55: 4196-4200
32. Waugh JM, Yuksel E, Li J, Kuo MD, Kattash M, Saxena R, Geske R, Thung SN, Shenaq SM, Woo SL (1999) Local overexpression of thrombomodulin for in vivo prevention of arterial thrombosis in a rabbit model. Circ Res 84: 84-92
33. Weiler H, Isermann BH (2003) Thrombomodulin. J Thromb Haemost 1: 1515-1524
34. Weiler H, Lindner V, Kerlin B, Isermann BH, Hendrickson SB, Cooley BC, Meh DA, Mosesson MW, Shworak NW, Post MJ, Conway EM, Ulfman LH, von Andrian UH, Weitz JI (2001) Characterization of a mouse model for thrombomodulin deficiency. Arterioscler Thromb Vasc Biol 21: 1531-1537
35. Wilhelm S, Schmitt M, Parkinson J, Kuhn W, Graeff H, Wilhelm OG (1998) Thrombomodulin, a receptor for the serine protease thrombin, is decreased in primary tumors and metastases but increased in ascitic fluids of patients with advanced ovarian cancer FIGO IIIc. Int J Oncol 13: 645-651
36. Yonezawa S, Maruyama I, Sakae K, Igata A, Majerus PW, Sato E (1987) Thrombomodulin as a marker for vascular tumors. Comparative study with factor VIII and Ulex europaeus I lectin. Am J Clin Pathol 88: 405-411
37. Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, Nakagawa K, Klevesath M, Wilhelm S, Bohrer H, Nakagawa M, Graeff H, Martin E, Stern DM, Rosenberg RD, Ziegler R, Nawroth PP (1998) Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Invest 101: 1301-1309